Exchange: NASDAQ·Updated 07:32 PM EST

GENB News

News
all
press releases
Generate Biomedicines (NASDAQ:GENB) Given New $21.00 Price Target at Morgan Stanley
Morgan Stanley lowered their price objective on shares of Generate Biomedicines from $22.00 to $21.00 and set an "overweight" rating for the company in a research report on Wednesday...
MarketBeat
Generate Biomedicines (NASDAQ:GENB) Given New $21.00 Price Target at Morgan Stanley
Morgan Stanley lowered their price objective on shares of Generate Biomedicines from $22.00 to $21.00 and set an "overweight" rating for the company in a research report on Wednesday...
MarketBeat
More News
Generate Biomedicines (NASDAQ:GENB) Hits New 1-Year Low - Should You Sell...
MarketBeat
Generate Biomedicines Inc (NASDAQ:GENB - Free Report) - Research analysts at HC Wainwright dropped their FY2026 earnings estimates for Generate Biomedicines in a research report issued on Friday, November 13th. HC Wainwright analyst M. Kapoor now expects that the company will post earnings per share...
MarketBeat
Generate Biomedicines (NASDAQ:GENB) Shares Down 9.7% - Here's What Happened...
MarketBeat
Deals for AI discovery platforms and differentiated experimental candidates for obesity and solid tumors dominated the week.
Stocktwits
Generate Biomedicines & Zealand Pharma team up to develop AI-engineered protein therapies for obesity & metabolic diseases.read more...
Benzinga
Generate Biomedicines CTO says Nvidia GPUs are essential, but data and experimentation will determine AI drug discovery winners.read more...
Benzinga
Generate Biomedicines says AI could make biology programmable by generating and testing drug hypotheses at machine scale.read more...
Benzinga
Generate Biomedicines co-founder & CTO says Nvidia's biggest contribution to AI drug discovery is technical collaboration, not just capital.read more...
Benzinga
Key PointsThe chipmaker has active interests in the healthcare market, including a partnership with Eli Lilly and an investment in small biotech Generate Biomedicines...
Nasdaq News: Markets

Advertisement|Remove ads.